nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—ALB—hematologic cancer	0.281	1	CbGaD
Auranofin—ALB—Imatinib—hematologic cancer	0.0332	0.383	CbGbCtD
Auranofin—ALB—Prednisone—hematologic cancer	0.0218	0.252	CbGbCtD
Auranofin—ALB—Irinotecan—hematologic cancer	0.0207	0.239	CbGbCtD
Auranofin—ALB—Methotrexate—hematologic cancer	0.011	0.126	CbGbCtD
Auranofin—PRDX5—hematopoietic system—hematologic cancer	0.00968	0.138	CbGeAlD
Auranofin—PRDX5—gonad—hematologic cancer	0.00736	0.105	CbGeAlD
Auranofin—PRDX5—blood—hematologic cancer	0.00641	0.0913	CbGeAlD
Auranofin—PRDX5—bone marrow—hematologic cancer	0.0062	0.0884	CbGeAlD
Auranofin—IKBKB—hematopoietic system—hematologic cancer	0.00573	0.0816	CbGeAlD
Auranofin—PRDX5—lung—hematologic cancer	0.00562	0.0801	CbGeAlD
Auranofin—PRDX5—testis—hematologic cancer	0.0053	0.0755	CbGeAlD
Auranofin—IKBKB—gonad—hematologic cancer	0.00436	0.0621	CbGeAlD
Auranofin—PRDX5—lymph node—hematologic cancer	0.00384	0.0547	CbGeAlD
Auranofin—IKBKB—blood—hematologic cancer	0.0038	0.0541	CbGeAlD
Auranofin—IKBKB—lung—hematologic cancer	0.00333	0.0474	CbGeAlD
Auranofin—IKBKB—testis—hematologic cancer	0.00314	0.0447	CbGeAlD
Auranofin—IKBKB—lymph node—hematologic cancer	0.00228	0.0324	CbGeAlD
Auranofin—ALB—testis—hematologic cancer	0.00183	0.0261	CbGeAlD
Auranofin—ALB—lymph node—hematologic cancer	0.00133	0.0189	CbGeAlD
Auranofin—Abdominal pain—Carmustine—hematologic cancer	0.000125	0.000407	CcSEcCtD
Auranofin—Dermatitis—Lenalidomide—hematologic cancer	0.000125	0.000407	CcSEcCtD
Auranofin—Diarrhoea—Bortezomib—hematologic cancer	0.000125	0.000407	CcSEcCtD
Auranofin—Decreased appetite—Gemcitabine—hematologic cancer	0.000124	0.000406	CcSEcCtD
Auranofin—Urticaria—Alitretinoin—hematologic cancer	0.000124	0.000406	CcSEcCtD
Auranofin—Vomiting—Hydroxyurea—hematologic cancer	0.000124	0.000405	CcSEcCtD
Auranofin—Angioedema—Triamcinolone—hematologic cancer	0.000124	0.000405	CcSEcCtD
Auranofin—Abdominal pain—Alitretinoin—hematologic cancer	0.000123	0.000404	CcSEcCtD
Auranofin—Gastrointestinal pain—Vincristine—hematologic cancer	0.000123	0.000402	CcSEcCtD
Auranofin—Rash—Hydroxyurea—hematologic cancer	0.000123	0.000402	CcSEcCtD
Auranofin—Dermatitis—Hydroxyurea—hematologic cancer	0.000123	0.000402	CcSEcCtD
Auranofin—Urticaria—Ifosfamide—hematologic cancer	0.000123	0.000401	CcSEcCtD
Auranofin—Constipation—Gemcitabine—hematologic cancer	0.000122	0.000399	CcSEcCtD
Auranofin—Abdominal pain—Ifosfamide—hematologic cancer	0.000122	0.000399	CcSEcCtD
Auranofin—Pancytopenia—Methotrexate—hematologic cancer	0.000122	0.000399	CcSEcCtD
Auranofin—Diarrhoea—Vinorelbine—hematologic cancer	0.000122	0.000397	CcSEcCtD
Auranofin—Nausea—Melphalan—hematologic cancer	0.000121	0.000395	CcSEcCtD
Auranofin—Dysphagia—Epirubicin—hematologic cancer	0.00012	0.000393	CcSEcCtD
Auranofin—Neutropenia—Methotrexate—hematologic cancer	0.00012	0.000392	CcSEcCtD
Auranofin—Pruritus—Thiotepa—hematologic cancer	0.00012	0.000392	CcSEcCtD
Auranofin—Gastrointestinal pain—Mitoxantrone—hematologic cancer	0.00012	0.000392	CcSEcCtD
Auranofin—Gastrointestinal pain—Irinotecan—hematologic cancer	0.00012	0.000392	CcSEcCtD
Auranofin—Thrombocytopenia—Etoposide—hematologic cancer	0.000119	0.00039	CcSEcCtD
Auranofin—Eosinophilia—Epirubicin—hematologic cancer	0.000119	0.000389	CcSEcCtD
Auranofin—Abdominal pain—Vincristine—hematologic cancer	0.000119	0.000389	CcSEcCtD
Auranofin—Nausea—Lenalidomide—hematologic cancer	0.000117	0.000384	CcSEcCtD
Auranofin—Urticaria—Mitoxantrone—hematologic cancer	0.000116	0.000381	CcSEcCtD
Auranofin—Anorexia—Etoposide—hematologic cancer	0.000116	0.00038	CcSEcCtD
Auranofin—Pruritus—Thalidomide—hematologic cancer	0.000116	0.00038	CcSEcCtD
Auranofin—Diarrhoea—Thiotepa—hematologic cancer	0.000116	0.00038	CcSEcCtD
Auranofin—Abdominal pain—Irinotecan—hematologic cancer	0.000116	0.000379	CcSEcCtD
Auranofin—Abdominal pain—Mitoxantrone—hematologic cancer	0.000116	0.000379	CcSEcCtD
Auranofin—Nausea—Hydroxyurea—hematologic cancer	0.000116	0.000379	CcSEcCtD
Auranofin—Vomiting—Bortezomib—hematologic cancer	0.000116	0.000378	CcSEcCtD
Auranofin—Decreased appetite—Cisplatin—hematologic cancer	0.000116	0.000378	CcSEcCtD
Auranofin—Eye disorder—Prednisone—hematologic cancer	0.000115	0.000376	CcSEcCtD
Auranofin—Vomiting—Bleomycin—hematologic cancer	0.000115	0.000375	CcSEcCtD
Auranofin—Rash—Bortezomib—hematologic cancer	0.000115	0.000375	CcSEcCtD
Auranofin—Dermatitis—Bortezomib—hematologic cancer	0.000115	0.000375	CcSEcCtD
Auranofin—Pancytopenia—Epirubicin—hematologic cancer	0.000114	0.000373	CcSEcCtD
Auranofin—Rash—Bleomycin—hematologic cancer	0.000114	0.000372	CcSEcCtD
Auranofin—Dermatitis—Bleomycin—hematologic cancer	0.000114	0.000372	CcSEcCtD
Auranofin—Vomiting—Vinorelbine—hematologic cancer	0.000113	0.000369	CcSEcCtD
Auranofin—Neutropenia—Epirubicin—hematologic cancer	0.000112	0.000367	CcSEcCtD
Auranofin—Angioedema—Betamethasone—hematologic cancer	0.000112	0.000367	CcSEcCtD
Auranofin—Angioedema—Dexamethasone—hematologic cancer	0.000112	0.000367	CcSEcCtD
Auranofin—Diarrhoea—Thalidomide—hematologic cancer	0.000112	0.000367	CcSEcCtD
Auranofin—Rash—Vinorelbine—hematologic cancer	0.000112	0.000366	CcSEcCtD
Auranofin—Dermatitis—Vinorelbine—hematologic cancer	0.000112	0.000366	CcSEcCtD
Auranofin—Stomatitis—Methotrexate—hematologic cancer	0.000112	0.000365	CcSEcCtD
Auranofin—Conjunctivitis—Methotrexate—hematologic cancer	0.000111	0.000364	CcSEcCtD
Auranofin—Dysphagia—Doxorubicin—hematologic cancer	0.000111	0.000363	CcSEcCtD
Auranofin—Pruritus—Alitretinoin—hematologic cancer	0.00011	0.000361	CcSEcCtD
Auranofin—Eosinophilia—Doxorubicin—hematologic cancer	0.00011	0.00036	CcSEcCtD
Auranofin—Pruritus—Ifosfamide—hematologic cancer	0.000109	0.000357	CcSEcCtD
Auranofin—Haematuria—Methotrexate—hematologic cancer	0.000109	0.000357	CcSEcCtD
Auranofin—Weight decreased—Epirubicin—hematologic cancer	0.000109	0.000355	CcSEcCtD
Auranofin—Alopecia—Prednisone—hematologic cancer	0.000109	0.000355	CcSEcCtD
Auranofin—Nausea—Bortezomib—hematologic cancer	0.000108	0.000353	CcSEcCtD
Auranofin—Vomiting—Thiotepa—hematologic cancer	0.000108	0.000353	CcSEcCtD
Auranofin—Diarrhoea—Carmustine—hematologic cancer	0.000108	0.000353	CcSEcCtD
Auranofin—Nausea—Bleomycin—hematologic cancer	0.000107	0.000351	CcSEcCtD
Auranofin—Rash—Thiotepa—hematologic cancer	0.000107	0.00035	CcSEcCtD
Auranofin—Dermatitis—Thiotepa—hematologic cancer	0.000107	0.000349	CcSEcCtD
Auranofin—Diarrhoea—Alitretinoin—hematologic cancer	0.000107	0.000349	CcSEcCtD
Auranofin—Agranulocytosis—Methotrexate—hematologic cancer	0.000107	0.000349	CcSEcCtD
Auranofin—Decreased appetite—Etoposide—hematologic cancer	0.000106	0.000346	CcSEcCtD
Auranofin—Diarrhoea—Ifosfamide—hematologic cancer	0.000106	0.000345	CcSEcCtD
Auranofin—Pancytopenia—Doxorubicin—hematologic cancer	0.000106	0.000345	CcSEcCtD
Auranofin—Nausea—Vinorelbine—hematologic cancer	0.000106	0.000345	CcSEcCtD
Auranofin—Neuropathy peripheral—Epirubicin—hematologic cancer	0.000105	0.000343	CcSEcCtD
Auranofin—Stomatitis—Epirubicin—hematologic cancer	0.000104	0.000341	CcSEcCtD
Auranofin—Jaundice—Epirubicin—hematologic cancer	0.000104	0.000341	CcSEcCtD
Auranofin—Vomiting—Thalidomide—hematologic cancer	0.000104	0.000341	CcSEcCtD
Auranofin—Constipation—Etoposide—hematologic cancer	0.000104	0.000341	CcSEcCtD
Auranofin—Conjunctivitis—Epirubicin—hematologic cancer	0.000104	0.00034	CcSEcCtD
Auranofin—Neutropenia—Doxorubicin—hematologic cancer	0.000104	0.00034	CcSEcCtD
Auranofin—Rash—Thalidomide—hematologic cancer	0.000103	0.000338	CcSEcCtD
Auranofin—Dermatitis—Thalidomide—hematologic cancer	0.000103	0.000338	CcSEcCtD
Auranofin—Diarrhoea—Vincristine—hematologic cancer	0.000103	0.000337	CcSEcCtD
Auranofin—Haematuria—Epirubicin—hematologic cancer	0.000102	0.000334	CcSEcCtD
Auranofin—Pruritus—Gemcitabine—hematologic cancer	0.000101	0.00033	CcSEcCtD
Auranofin—Nausea—Thiotepa—hematologic cancer	0.000101	0.000329	CcSEcCtD
Auranofin—Weight decreased—Doxorubicin—hematologic cancer	0.000101	0.000329	CcSEcCtD
Auranofin—Diarrhoea—Mitoxantrone—hematologic cancer	0.0001	0.000328	CcSEcCtD
Auranofin—Diarrhoea—Irinotecan—hematologic cancer	0.0001	0.000328	CcSEcCtD
Auranofin—Vomiting—Carmustine—hematologic cancer	0.0001	0.000328	CcSEcCtD
Auranofin—Agranulocytosis—Epirubicin—hematologic cancer	0.0001	0.000327	CcSEcCtD
Auranofin—Gastrointestinal pain—Etoposide—hematologic cancer	9.97e-05	0.000326	CcSEcCtD
Auranofin—Rash—Carmustine—hematologic cancer	9.94e-05	0.000325	CcSEcCtD
Auranofin—Dermatitis—Carmustine—hematologic cancer	9.93e-05	0.000325	CcSEcCtD
Auranofin—Vomiting—Alitretinoin—hematologic cancer	9.93e-05	0.000325	CcSEcCtD
Auranofin—Visual impairment—Methotrexate—hematologic cancer	9.9e-05	0.000324	CcSEcCtD
Auranofin—Anaemia—Prednisone—hematologic cancer	9.9e-05	0.000323	CcSEcCtD
Auranofin—Rash—Alitretinoin—hematologic cancer	9.85e-05	0.000322	CcSEcCtD
Auranofin—Dermatitis—Alitretinoin—hematologic cancer	9.84e-05	0.000322	CcSEcCtD
Auranofin—Thrombocytopenia—Dexamethasone—hematologic cancer	9.82e-05	0.000321	CcSEcCtD
Auranofin—Thrombocytopenia—Betamethasone—hematologic cancer	9.82e-05	0.000321	CcSEcCtD
Auranofin—Vomiting—Ifosfamide—hematologic cancer	9.81e-05	0.000321	CcSEcCtD
Auranofin—Angioedema—Prednisone—hematologic cancer	9.78e-05	0.00032	CcSEcCtD
Auranofin—Diarrhoea—Gemcitabine—hematologic cancer	9.77e-05	0.000319	CcSEcCtD
Auranofin—Nausea—Thalidomide—hematologic cancer	9.75e-05	0.000319	CcSEcCtD
Auranofin—Dyspepsia—Triamcinolone—hematologic cancer	9.73e-05	0.000318	CcSEcCtD
Auranofin—Rash—Ifosfamide—hematologic cancer	9.73e-05	0.000318	CcSEcCtD
Auranofin—Dermatitis—Ifosfamide—hematologic cancer	9.72e-05	0.000318	CcSEcCtD
Auranofin—Neuropathy peripheral—Doxorubicin—hematologic cancer	9.72e-05	0.000318	CcSEcCtD
Auranofin—Urticaria—Etoposide—hematologic cancer	9.68e-05	0.000317	CcSEcCtD
Auranofin—Stomatitis—Doxorubicin—hematologic cancer	9.66e-05	0.000316	CcSEcCtD
Auranofin—Jaundice—Doxorubicin—hematologic cancer	9.66e-05	0.000316	CcSEcCtD
Auranofin—Abdominal pain—Etoposide—hematologic cancer	9.64e-05	0.000315	CcSEcCtD
Auranofin—Conjunctivitis—Doxorubicin—hematologic cancer	9.64e-05	0.000315	CcSEcCtD
Auranofin—Eye disorder—Methotrexate—hematologic cancer	9.61e-05	0.000314	CcSEcCtD
Auranofin—Vomiting—Vincristine—hematologic cancer	9.57e-05	0.000313	CcSEcCtD
Auranofin—Anorexia—Dexamethasone—hematologic cancer	9.56e-05	0.000313	CcSEcCtD
Auranofin—Anorexia—Betamethasone—hematologic cancer	9.56e-05	0.000313	CcSEcCtD
Auranofin—Urticaria—Prednisolone—hematologic cancer	9.55e-05	0.000312	CcSEcCtD
Auranofin—Rash—Vincristine—hematologic cancer	9.49e-05	0.00031	CcSEcCtD
Auranofin—Dermatitis—Vincristine—hematologic cancer	9.48e-05	0.00031	CcSEcCtD
Auranofin—Haematuria—Doxorubicin—hematologic cancer	9.45e-05	0.000309	CcSEcCtD
Auranofin—Nausea—Carmustine—hematologic cancer	9.36e-05	0.000306	CcSEcCtD
Auranofin—Vomiting—Irinotecan—hematologic cancer	9.32e-05	0.000305	CcSEcCtD
Auranofin—Vomiting—Mitoxantrone—hematologic cancer	9.32e-05	0.000305	CcSEcCtD
Auranofin—Nausea—Alitretinoin—hematologic cancer	9.28e-05	0.000303	CcSEcCtD
Auranofin—Visual impairment—Epirubicin—hematologic cancer	9.27e-05	0.000303	CcSEcCtD
Auranofin—Agranulocytosis—Doxorubicin—hematologic cancer	9.25e-05	0.000302	CcSEcCtD
Auranofin—Rash—Irinotecan—hematologic cancer	9.24e-05	0.000302	CcSEcCtD
Auranofin—Rash—Mitoxantrone—hematologic cancer	9.24e-05	0.000302	CcSEcCtD
Auranofin—Dermatitis—Mitoxantrone—hematologic cancer	9.23e-05	0.000302	CcSEcCtD
Auranofin—Dermatitis—Irinotecan—hematologic cancer	9.23e-05	0.000302	CcSEcCtD
Auranofin—Nausea—Ifosfamide—hematologic cancer	9.17e-05	0.0003	CcSEcCtD
Auranofin—Diarrhoea—Cisplatin—hematologic cancer	9.1e-05	0.000298	CcSEcCtD
Auranofin—Alopecia—Methotrexate—hematologic cancer	9.08e-05	0.000297	CcSEcCtD
Auranofin—Vomiting—Gemcitabine—hematologic cancer	9.08e-05	0.000297	CcSEcCtD
Auranofin—Rash—Gemcitabine—hematologic cancer	9e-05	0.000294	CcSEcCtD
Auranofin—Dermatitis—Gemcitabine—hematologic cancer	8.99e-05	0.000294	CcSEcCtD
Auranofin—Eye disorder—Epirubicin—hematologic cancer	8.99e-05	0.000294	CcSEcCtD
Auranofin—Nausea—Vincristine—hematologic cancer	8.94e-05	0.000292	CcSEcCtD
Auranofin—Dyspepsia—Betamethasone—hematologic cancer	8.83e-05	0.000289	CcSEcCtD
Auranofin—Dyspepsia—Dexamethasone—hematologic cancer	8.83e-05	0.000289	CcSEcCtD
Auranofin—Urticaria—Triamcinolone—hematologic cancer	8.78e-05	0.000287	CcSEcCtD
Auranofin—Dysgeusia—Methotrexate—hematologic cancer	8.76e-05	0.000286	CcSEcCtD
Auranofin—Decreased appetite—Dexamethasone—hematologic cancer	8.72e-05	0.000285	CcSEcCtD
Auranofin—Decreased appetite—Betamethasone—hematologic cancer	8.72e-05	0.000285	CcSEcCtD
Auranofin—Nausea—Mitoxantrone—hematologic cancer	8.71e-05	0.000285	CcSEcCtD
Auranofin—Nausea—Irinotecan—hematologic cancer	8.71e-05	0.000285	CcSEcCtD
Auranofin—Pruritus—Etoposide—hematologic cancer	8.62e-05	0.000282	CcSEcCtD
Auranofin—Visual impairment—Doxorubicin—hematologic cancer	8.58e-05	0.00028	CcSEcCtD
Auranofin—Alopecia—Epirubicin—hematologic cancer	8.5e-05	0.000278	CcSEcCtD
Auranofin—Nausea—Gemcitabine—hematologic cancer	8.48e-05	0.000277	CcSEcCtD
Auranofin—Vomiting—Cisplatin—hematologic cancer	8.46e-05	0.000277	CcSEcCtD
Auranofin—Rash—Cisplatin—hematologic cancer	8.39e-05	0.000274	CcSEcCtD
Auranofin—Dermatitis—Cisplatin—hematologic cancer	8.38e-05	0.000274	CcSEcCtD
Auranofin—Diarrhoea—Etoposide—hematologic cancer	8.34e-05	0.000273	CcSEcCtD
Auranofin—Anorexia—Prednisone—hematologic cancer	8.33e-05	0.000272	CcSEcCtD
Auranofin—Eye disorder—Doxorubicin—hematologic cancer	8.32e-05	0.000272	CcSEcCtD
Auranofin—Anaemia—Methotrexate—hematologic cancer	8.27e-05	0.00027	CcSEcCtD
Auranofin—Flatulence—Epirubicin—hematologic cancer	8.25e-05	0.00027	CcSEcCtD
Auranofin—Gastrointestinal pain—Betamethasone—hematologic cancer	8.2e-05	0.000268	CcSEcCtD
Auranofin—Gastrointestinal pain—Dexamethasone—hematologic cancer	8.2e-05	0.000268	CcSEcCtD
Auranofin—Dysgeusia—Epirubicin—hematologic cancer	8.2e-05	0.000268	CcSEcCtD
Auranofin—Leukopenia—Methotrexate—hematologic cancer	8.01e-05	0.000262	CcSEcCtD
Auranofin—Urticaria—Dexamethasone—hematologic cancer	7.97e-05	0.000261	CcSEcCtD
Auranofin—Urticaria—Betamethasone—hematologic cancer	7.97e-05	0.000261	CcSEcCtD
Auranofin—Abdominal pain—Betamethasone—hematologic cancer	7.93e-05	0.000259	CcSEcCtD
Auranofin—Abdominal pain—Dexamethasone—hematologic cancer	7.93e-05	0.000259	CcSEcCtD
Auranofin—Nausea—Cisplatin—hematologic cancer	7.9e-05	0.000258	CcSEcCtD
Auranofin—Alopecia—Doxorubicin—hematologic cancer	7.86e-05	0.000257	CcSEcCtD
Auranofin—Pruritus—Triamcinolone—hematologic cancer	7.82e-05	0.000256	CcSEcCtD
Auranofin—Vomiting—Etoposide—hematologic cancer	7.75e-05	0.000253	CcSEcCtD
Auranofin—Anaemia—Epirubicin—hematologic cancer	7.74e-05	0.000253	CcSEcCtD
Auranofin—Dyspepsia—Prednisone—hematologic cancer	7.69e-05	0.000251	CcSEcCtD
Auranofin—Rash—Etoposide—hematologic cancer	7.69e-05	0.000251	CcSEcCtD
Auranofin—Dermatitis—Etoposide—hematologic cancer	7.68e-05	0.000251	CcSEcCtD
Auranofin—Flatulence—Doxorubicin—hematologic cancer	7.63e-05	0.00025	CcSEcCtD
Auranofin—Decreased appetite—Prednisone—hematologic cancer	7.6e-05	0.000248	CcSEcCtD
Auranofin—Dysgeusia—Doxorubicin—hematologic cancer	7.59e-05	0.000248	CcSEcCtD
Auranofin—Rash—Prednisolone—hematologic cancer	7.58e-05	0.000248	CcSEcCtD
Auranofin—Dermatitis—Prednisolone—hematologic cancer	7.57e-05	0.000248	CcSEcCtD
Auranofin—Leukopenia—Epirubicin—hematologic cancer	7.49e-05	0.000245	CcSEcCtD
Auranofin—Constipation—Prednisone—hematologic cancer	7.47e-05	0.000244	CcSEcCtD
Auranofin—Nausea—Etoposide—hematologic cancer	7.24e-05	0.000237	CcSEcCtD
Auranofin—Anaemia—Doxorubicin—hematologic cancer	7.16e-05	0.000234	CcSEcCtD
Auranofin—Thrombocytopenia—Methotrexate—hematologic cancer	7.15e-05	0.000234	CcSEcCtD
Auranofin—Gastrointestinal pain—Prednisone—hematologic cancer	7.14e-05	0.000234	CcSEcCtD
Auranofin—Nausea—Prednisolone—hematologic cancer	7.14e-05	0.000233	CcSEcCtD
Auranofin—Pruritus—Dexamethasone—hematologic cancer	7.1e-05	0.000232	CcSEcCtD
Auranofin—Pruritus—Betamethasone—hematologic cancer	7.1e-05	0.000232	CcSEcCtD
Auranofin—Vomiting—Triamcinolone—hematologic cancer	7.03e-05	0.00023	CcSEcCtD
Auranofin—Rash—Triamcinolone—hematologic cancer	6.97e-05	0.000228	CcSEcCtD
Auranofin—Dermatitis—Triamcinolone—hematologic cancer	6.97e-05	0.000228	CcSEcCtD
Auranofin—Anorexia—Methotrexate—hematologic cancer	6.96e-05	0.000228	CcSEcCtD
Auranofin—Urticaria—Prednisone—hematologic cancer	6.94e-05	0.000227	CcSEcCtD
Auranofin—Leukopenia—Doxorubicin—hematologic cancer	6.93e-05	0.000227	CcSEcCtD
Auranofin—Abdominal pain—Prednisone—hematologic cancer	6.91e-05	0.000226	CcSEcCtD
Auranofin—Diarrhoea—Betamethasone—hematologic cancer	6.86e-05	0.000224	CcSEcCtD
Auranofin—Diarrhoea—Dexamethasone—hematologic cancer	6.86e-05	0.000224	CcSEcCtD
Auranofin—Thrombocytopenia—Epirubicin—hematologic cancer	6.69e-05	0.000219	CcSEcCtD
Auranofin—Nausea—Triamcinolone—hematologic cancer	6.57e-05	0.000215	CcSEcCtD
Auranofin—Anorexia—Epirubicin—hematologic cancer	6.51e-05	0.000213	CcSEcCtD
Auranofin—Dyspepsia—Methotrexate—hematologic cancer	6.43e-05	0.00021	CcSEcCtD
Auranofin—Vomiting—Dexamethasone—hematologic cancer	6.38e-05	0.000209	CcSEcCtD
Auranofin—Vomiting—Betamethasone—hematologic cancer	6.38e-05	0.000209	CcSEcCtD
Auranofin—Decreased appetite—Methotrexate—hematologic cancer	6.35e-05	0.000207	CcSEcCtD
Auranofin—Rash—Betamethasone—hematologic cancer	6.33e-05	0.000207	CcSEcCtD
Auranofin—Rash—Dexamethasone—hematologic cancer	6.33e-05	0.000207	CcSEcCtD
Auranofin—Dermatitis—Dexamethasone—hematologic cancer	6.32e-05	0.000207	CcSEcCtD
Auranofin—Dermatitis—Betamethasone—hematologic cancer	6.32e-05	0.000207	CcSEcCtD
Auranofin—Thrombocytopenia—Doxorubicin—hematologic cancer	6.19e-05	0.000202	CcSEcCtD
Auranofin—Pruritus—Prednisone—hematologic cancer	6.18e-05	0.000202	CcSEcCtD
Auranofin—Anorexia—Doxorubicin—hematologic cancer	6.03e-05	0.000197	CcSEcCtD
Auranofin—Dyspepsia—Epirubicin—hematologic cancer	6.02e-05	0.000197	CcSEcCtD
Auranofin—Diarrhoea—Prednisone—hematologic cancer	5.98e-05	0.000195	CcSEcCtD
Auranofin—Gastrointestinal pain—Methotrexate—hematologic cancer	5.97e-05	0.000195	CcSEcCtD
Auranofin—Nausea—Dexamethasone—hematologic cancer	5.96e-05	0.000195	CcSEcCtD
Auranofin—Nausea—Betamethasone—hematologic cancer	5.96e-05	0.000195	CcSEcCtD
Auranofin—Decreased appetite—Epirubicin—hematologic cancer	5.94e-05	0.000194	CcSEcCtD
Auranofin—Constipation—Epirubicin—hematologic cancer	5.84e-05	0.000191	CcSEcCtD
Auranofin—Urticaria—Methotrexate—hematologic cancer	5.8e-05	0.00019	CcSEcCtD
Auranofin—Abdominal pain—Methotrexate—hematologic cancer	5.77e-05	0.000189	CcSEcCtD
Auranofin—Gastrointestinal pain—Epirubicin—hematologic cancer	5.59e-05	0.000183	CcSEcCtD
Auranofin—Dyspepsia—Doxorubicin—hematologic cancer	5.57e-05	0.000182	CcSEcCtD
Auranofin—Vomiting—Prednisone—hematologic cancer	5.56e-05	0.000182	CcSEcCtD
Auranofin—Rash—Prednisone—hematologic cancer	5.51e-05	0.00018	CcSEcCtD
Auranofin—Dermatitis—Prednisone—hematologic cancer	5.5e-05	0.00018	CcSEcCtD
Auranofin—Decreased appetite—Doxorubicin—hematologic cancer	5.5e-05	0.00018	CcSEcCtD
Auranofin—Urticaria—Epirubicin—hematologic cancer	5.43e-05	0.000177	CcSEcCtD
Auranofin—Constipation—Doxorubicin—hematologic cancer	5.41e-05	0.000177	CcSEcCtD
Auranofin—Abdominal pain—Epirubicin—hematologic cancer	5.4e-05	0.000177	CcSEcCtD
Auranofin—Nausea—Prednisone—hematologic cancer	5.19e-05	0.00017	CcSEcCtD
Auranofin—Gastrointestinal pain—Doxorubicin—hematologic cancer	5.17e-05	0.000169	CcSEcCtD
Auranofin—Pruritus—Methotrexate—hematologic cancer	5.17e-05	0.000169	CcSEcCtD
Auranofin—Urticaria—Doxorubicin—hematologic cancer	5.02e-05	0.000164	CcSEcCtD
Auranofin—Abdominal pain—Doxorubicin—hematologic cancer	5e-05	0.000163	CcSEcCtD
Auranofin—Diarrhoea—Methotrexate—hematologic cancer	5e-05	0.000163	CcSEcCtD
Auranofin—Pruritus—Epirubicin—hematologic cancer	4.83e-05	0.000158	CcSEcCtD
Auranofin—Diarrhoea—Epirubicin—hematologic cancer	4.68e-05	0.000153	CcSEcCtD
Auranofin—Vomiting—Methotrexate—hematologic cancer	4.64e-05	0.000152	CcSEcCtD
Auranofin—Rash—Methotrexate—hematologic cancer	4.6e-05	0.00015	CcSEcCtD
Auranofin—Dermatitis—Methotrexate—hematologic cancer	4.6e-05	0.00015	CcSEcCtD
Auranofin—Pruritus—Doxorubicin—hematologic cancer	4.47e-05	0.000146	CcSEcCtD
Auranofin—Vomiting—Epirubicin—hematologic cancer	4.34e-05	0.000142	CcSEcCtD
Auranofin—Nausea—Methotrexate—hematologic cancer	4.34e-05	0.000142	CcSEcCtD
Auranofin—Diarrhoea—Doxorubicin—hematologic cancer	4.33e-05	0.000141	CcSEcCtD
Auranofin—Rash—Epirubicin—hematologic cancer	4.31e-05	0.000141	CcSEcCtD
Auranofin—Dermatitis—Epirubicin—hematologic cancer	4.3e-05	0.000141	CcSEcCtD
Auranofin—Nausea—Epirubicin—hematologic cancer	4.06e-05	0.000133	CcSEcCtD
Auranofin—Vomiting—Doxorubicin—hematologic cancer	4.02e-05	0.000131	CcSEcCtD
Auranofin—Rash—Doxorubicin—hematologic cancer	3.99e-05	0.00013	CcSEcCtD
Auranofin—Dermatitis—Doxorubicin—hematologic cancer	3.98e-05	0.00013	CcSEcCtD
Auranofin—Nausea—Doxorubicin—hematologic cancer	3.76e-05	0.000123	CcSEcCtD
Auranofin—IKBKB—Innate Immune System—CD4—hematologic cancer	1.55e-05	6.05e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—FOXO1—hematologic cancer	1.55e-05	6.05e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—IDH2—hematologic cancer	1.55e-05	6.04e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—HMMR—hematologic cancer	1.55e-05	6.04e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PDGFRB—hematologic cancer	1.55e-05	6.04e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—HRAS—hematologic cancer	1.54e-05	5.99e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PTGER4—hematologic cancer	1.53e-05	5.99e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—MDM2—hematologic cancer	1.53e-05	5.98e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—JAK1—hematologic cancer	1.53e-05	5.97e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PRKCG—hematologic cancer	1.53e-05	5.97e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—LCK—hematologic cancer	1.53e-05	5.96e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PDGFRA—hematologic cancer	1.52e-05	5.94e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PRKCG—hematologic cancer	1.52e-05	5.92e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—JAK1—hematologic cancer	1.52e-05	5.92e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HLA-B—hematologic cancer	1.51e-05	5.9e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—H3F3A—hematologic cancer	1.5e-05	5.84e-05	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL6—hematologic cancer	1.49e-05	5.83e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PIK3CB—hematologic cancer	1.49e-05	5.82e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—MTOR—hematologic cancer	1.49e-05	5.82e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD4—hematologic cancer	1.49e-05	5.81e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—IL6—hematologic cancer	1.47e-05	5.74e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.46e-05	5.69e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CDKN1B—hematologic cancer	1.46e-05	5.69e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PRKCZ—hematologic cancer	1.46e-05	5.68e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—ARNTL—hematologic cancer	1.45e-05	5.68e-05	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.43e-05	5.58e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IL2RA—hematologic cancer	1.43e-05	5.57e-05	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—SRC—hematologic cancer	1.42e-05	5.53e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL2RA—hematologic cancer	1.42e-05	5.53e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—ACP5—hematologic cancer	1.41e-05	5.52e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CA9—hematologic cancer	1.41e-05	5.52e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PARP1—hematologic cancer	1.41e-05	5.49e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HLA-A—hematologic cancer	1.4e-05	5.47e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CDKN1B—hematologic cancer	1.4e-05	5.46e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—NCOR2—hematologic cancer	1.4e-05	5.45e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—JUN—hematologic cancer	1.39e-05	5.41e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FBXW7—hematologic cancer	1.38e-05	5.4e-05	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—VEGFA—hematologic cancer	1.38e-05	5.39e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PDGFB—hematologic cancer	1.38e-05	5.38e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PDGFB—hematologic cancer	1.37e-05	5.34e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HDAC2—hematologic cancer	1.36e-05	5.29e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CXCR4—hematologic cancer	1.36e-05	5.29e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—AKT1—hematologic cancer	1.36e-05	5.29e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CDKN1A—hematologic cancer	1.34e-05	5.25e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—BCL2L1—hematologic cancer	1.34e-05	5.25e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PTEN—hematologic cancer	1.34e-05	5.24e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—CDK2—hematologic cancer	1.34e-05	5.22e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—TSC2—hematologic cancer	1.34e-05	5.22e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CRP—hematologic cancer	1.34e-05	5.22e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—IDH1—hematologic cancer	1.33e-05	5.19e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CBL—hematologic cancer	1.32e-05	5.16e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—ABCC3—hematologic cancer	1.31e-05	5.13e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—TXN—hematologic cancer	1.31e-05	5.13e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTO1—hematologic cancer	1.31e-05	5.13e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MAPK8—hematologic cancer	1.31e-05	5.12e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL3—hematologic cancer	1.31e-05	5.1e-05	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—MAPK3—hematologic cancer	1.31e-05	5.1e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CDKN1A—hematologic cancer	1.29e-05	5.04e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PTEN—hematologic cancer	1.29e-05	5.03e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—SPHK1—hematologic cancer	1.29e-05	5.02e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—FGFR3—hematologic cancer	1.29e-05	5.02e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PTPN1—hematologic cancer	1.29e-05	5.02e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—MAPK14—hematologic cancer	1.28e-05	5.01e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—EP300—hematologic cancer	1.28e-05	4.99e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MAPK14—hematologic cancer	1.27e-05	4.97e-05	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—TGFB1—hematologic cancer	1.27e-05	4.94e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RASGRP1—hematologic cancer	1.26e-05	4.94e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SYK—hematologic cancer	1.26e-05	4.92e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HSP90AA1—hematologic cancer	1.26e-05	4.92e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—SRC—hematologic cancer	1.24e-05	4.86e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—FN1—hematologic cancer	1.24e-05	4.85e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—UGT1A1—hematologic cancer	1.24e-05	4.83e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ICAM1—hematologic cancer	1.23e-05	4.79e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—NFKBIA—hematologic cancer	1.22e-05	4.76e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—BAD—hematologic cancer	1.22e-05	4.76e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—STAT1—hematologic cancer	1.22e-05	4.74e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—SLC22A1—hematologic cancer	1.2e-05	4.69e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CRABP1—hematologic cancer	1.2e-05	4.69e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—NRAS—hematologic cancer	1.2e-05	4.67e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—SRC—hematologic cancer	1.19e-05	4.66e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3CG—hematologic cancer	1.19e-05	4.64e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD80—hematologic cancer	1.18e-05	4.62e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—KIT—hematologic cancer	1.18e-05	4.61e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—ALOX5—hematologic cancer	1.17e-05	4.58e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PTPN11—hematologic cancer	1.17e-05	4.56e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PTPN11—hematologic cancer	1.16e-05	4.53e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—NRAS—hematologic cancer	1.15e-05	4.49e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MAPK3—hematologic cancer	1.15e-05	4.47e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GRB2—hematologic cancer	1.14e-05	4.44e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—NUP98—hematologic cancer	1.14e-05	4.43e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PDGFA—hematologic cancer	1.13e-05	4.43e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—FOS—hematologic cancer	1.13e-05	4.39e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CREB1—hematologic cancer	1.12e-05	4.39e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KITLG—hematologic cancer	1.12e-05	4.36e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—CREBBP—hematologic cancer	1.1e-05	4.3e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—ADCY7—hematologic cancer	1.1e-05	4.3e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—NCOA3—hematologic cancer	1.1e-05	4.3e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CASP8—hematologic cancer	1.1e-05	4.29e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL6R—hematologic cancer	1.1e-05	4.28e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—NUP214—hematologic cancer	1.09e-05	4.27e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CREBBP—hematologic cancer	1.09e-05	4.27e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—STAT5A—hematologic cancer	1.09e-05	4.27e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CDKN2B—hematologic cancer	1.08e-05	4.23e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.08e-05	4.23e-05	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	1.08e-05	4.21e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—MTR—hematologic cancer	1.07e-05	4.18e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—ABCG2—hematologic cancer	1.07e-05	4.18e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—ENO2—hematologic cancer	1.05e-05	4.1e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CD86—hematologic cancer	1.05e-05	4.09e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3CD—hematologic cancer	1.05e-05	4.08e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MAP2K1—hematologic cancer	1.04e-05	4.08e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PIK3CD—hematologic cancer	1.04e-05	4.05e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HES1—hematologic cancer	1.03e-05	4.03e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—KRAS—hematologic cancer	1.03e-05	4.02e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NCOR1—hematologic cancer	1.03e-05	4.01e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTT1—hematologic cancer	1.02e-05	3.98e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FGF1—hematologic cancer	1.02e-05	3.97e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CSF2—hematologic cancer	1.02e-05	3.97e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1e-05	3.92e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FOXO1—hematologic cancer	1e-05	3.91e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PDGFRB—hematologic cancer	1e-05	3.9e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—SDC1—hematologic cancer	9.97e-06	3.89e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—FGF2—hematologic cancer	9.93e-06	3.88e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—KRAS—hematologic cancer	9.89e-06	3.86e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3R1—hematologic cancer	9.87e-06	3.85e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PDGFRA—hematologic cancer	9.84e-06	3.84e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—JAK1—hematologic cancer	9.81e-06	3.83e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PRKCG—hematologic cancer	9.81e-06	3.83e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PIK3R1—hematologic cancer	9.8e-06	3.82e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—JAK2—hematologic cancer	9.6e-06	3.75e-05	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	9.55e-06	3.73e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—JAK2—hematologic cancer	9.52e-06	3.72e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	9.52e-06	3.72e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PIK3CA—hematologic cancer	9.46e-06	3.69e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—BCL2—hematologic cancer	9.43e-06	3.68e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IFNG—hematologic cancer	9.35e-06	3.65e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MDM2—hematologic cancer	9.29e-06	3.63e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL2RA—hematologic cancer	9.16e-06	3.58e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3CB—hematologic cancer	9.11e-06	3.56e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PIK3CA—hematologic cancer	9.09e-06	3.55e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TERT—hematologic cancer	9.06e-06	3.54e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MTOR—hematologic cancer	9.04e-06	3.53e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PIK3CB—hematologic cancer	9.04e-06	3.53e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD4—hematologic cancer	9.03e-06	3.52e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	8.99e-06	3.51e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PDGFB—hematologic cancer	8.84e-06	3.45e-05	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	8.81e-06	3.44e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—HRAS—hematologic cancer	8.76e-06	3.42e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TSC2—hematologic cancer	8.64e-06	3.37e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CDKN1B—hematologic cancer	8.49e-06	3.31e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—NQO1—hematologic cancer	8.47e-06	3.31e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CD44—hematologic cancer	8.47e-06	3.31e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—HRAS—hematologic cancer	8.41e-06	3.28e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IL6—hematologic cancer	8.38e-06	3.27e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IL2—hematologic cancer	8.37e-06	3.27e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL1B—hematologic cancer	8.34e-06	3.25e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FGFR3—hematologic cancer	8.31e-06	3.24e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL2—hematologic cancer	8.3e-06	3.24e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	8.3e-06	3.24e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MAPK14—hematologic cancer	8.23e-06	3.21e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—JUN—hematologic cancer	8.08e-06	3.15e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ESR1—hematologic cancer	8.07e-06	3.15e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYCS—hematologic cancer	8.02e-06	3.13e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FN1—hematologic cancer	7.97e-06	3.11e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—HSP90AA1—hematologic cancer	7.97e-06	3.11e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NFKBIA—hematologic cancer	7.88e-06	3.08e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—BAD—hematologic cancer	7.88e-06	3.08e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CDKN1A—hematologic cancer	7.83e-06	3.06e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PTEN—hematologic cancer	7.81e-06	3.05e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NOTCH1—hematologic cancer	7.8e-06	3.05e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—AKT1—hematologic cancer	7.73e-06	3.02e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MAPK8—hematologic cancer	7.64e-06	2.98e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CD80—hematologic cancer	7.64e-06	2.98e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KIT—hematologic cancer	7.63e-06	2.98e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3CG—hematologic cancer	7.63e-06	2.98e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—EP300—hematologic cancer	7.51e-06	2.93e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PTPN11—hematologic cancer	7.5e-06	2.93e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—EP300—hematologic cancer	7.45e-06	2.91e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—AKT1—hematologic cancer	7.42e-06	2.9e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—SRC—hematologic cancer	7.3e-06	2.85e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CREB1—hematologic cancer	7.26e-06	2.84e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—SRC—hematologic cancer	7.25e-06	2.83e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—BRAF—hematologic cancer	7.17e-06	2.8e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	7.17e-06	2.8e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—VEGFA—hematologic cancer	7.11e-06	2.78e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCL2—hematologic cancer	7.11e-06	2.77e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL6R—hematologic cancer	7.08e-06	2.77e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CREBBP—hematologic cancer	7.07e-06	2.76e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTP1—hematologic cancer	7.07e-06	2.76e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—NRAS—hematologic cancer	7.03e-06	2.74e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—STAT3—hematologic cancer	6.99e-06	2.73e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—NRAS—hematologic cancer	6.97e-06	2.72e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	6.84e-06	2.67e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MAP2K1—hematologic cancer	6.75e-06	2.64e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—MAPK3—hematologic cancer	6.73e-06	2.63e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3CD—hematologic cancer	6.71e-06	2.62e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—ABCB1—hematologic cancer	6.69e-06	2.61e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MAPK3—hematologic cancer	6.68e-06	2.61e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TGFB1—hematologic cancer	6.53e-06	2.55e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTM1—hematologic cancer	6.49e-06	2.54e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—NCOR1—hematologic cancer	6.49e-06	2.54e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FGF2—hematologic cancer	6.42e-06	2.51e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3R1—hematologic cancer	6.33e-06	2.47e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—JAK2—hematologic cancer	6.16e-06	2.4e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—KRAS—hematologic cancer	6.05e-06	2.36e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MDM2—hematologic cancer	6.01e-06	2.35e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—KRAS—hematologic cancer	6e-06	2.34e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3CB—hematologic cancer	5.85e-06	2.28e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MTOR—hematologic cancer	5.85e-06	2.28e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—MTHFR—hematologic cancer	5.74e-06	2.24e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3CA—hematologic cancer	5.56e-06	2.17e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PIK3CA—hematologic cancer	5.51e-06	2.15e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CDKN1B—hematologic cancer	5.49e-06	2.14e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CASP3—hematologic cancer	5.38e-06	2.1e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TP53—hematologic cancer	5.37e-06	2.1e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL2—hematologic cancer	5.37e-06	2.1e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCND1—hematologic cancer	5.23e-06	2.04e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—JUN—hematologic cancer	5.22e-06	2.04e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—HRAS—hematologic cancer	5.14e-06	2.01e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HRAS—hematologic cancer	5.1e-06	1.99e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CDKN1A—hematologic cancer	5.06e-06	1.98e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.06e-06	1.97e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PTEN—hematologic cancer	5.05e-06	1.97e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MAPK8—hematologic cancer	4.94e-06	1.93e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL6—hematologic cancer	4.88e-06	1.91e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3CG—hematologic cancer	4.82e-06	1.88e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—EP300—hematologic cancer	4.82e-06	1.88e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SRC—hematologic cancer	4.68e-06	1.83e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—VEGFA—hematologic cancer	4.56e-06	1.78e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—AKT1—hematologic cancer	4.54e-06	1.77e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—STAT3—hematologic cancer	4.52e-06	1.76e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NRAS—hematologic cancer	4.51e-06	1.76e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—AKT1—hematologic cancer	4.5e-06	1.76e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CREBBP—hematologic cancer	4.47e-06	1.75e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MAPK3—hematologic cancer	4.32e-06	1.69e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3CD—hematologic cancer	4.24e-06	1.65e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MYC—hematologic cancer	4.2e-06	1.64e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TGFB1—hematologic cancer	4.19e-06	1.63e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3R1—hematologic cancer	4e-06	1.56e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KRAS—hematologic cancer	3.88e-06	1.51e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3CB—hematologic cancer	3.7e-06	1.44e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3CA—hematologic cancer	3.56e-06	1.39e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TP53—hematologic cancer	3.45e-06	1.35e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HRAS—hematologic cancer	3.3e-06	1.29e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PTEN—hematologic cancer	3.19e-06	1.25e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL6—hematologic cancer	3.16e-06	1.23e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—EP300—hematologic cancer	3.05e-06	1.19e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AKT1—hematologic cancer	2.91e-06	1.14e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3CA—hematologic cancer	2.25e-06	8.79e-06	CbGpPWpGaD
Auranofin—ALB—Metabolism—AKT1—hematologic cancer	1.84e-06	7.18e-06	CbGpPWpGaD
